sincerely hope our trastuzumab biosimilar will do exactly that,” said Sang-Jin Pak, Senior Vice President and Head of Commercial Division, Samsung Bioepis.
×
Want to know more about the Kunena Project? See how the open source philosophy drives our community, follow our development on GitHub, and how you can participate to make Kunena even better.